Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: MHRA (Medicines & Healthcare Products Regulatory Agency)
Doxazosin mesilate
Mawdsley-Brooks & Company Ltd
C02CA04
Doxazosin mesilate
2mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050400
DOXADURA 1 MG TABLETS DOXADURA 2 MG TABLETS DOXADURA 4 MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • DOXADURA is a treatment for high blood pressure, or the symptoms caused by enlargement of the prostate gland in men. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • You should take DOXADURA regularly to get the maximum benefit, even if you are feeling well. • Most people do not have serious problems when taking DOXADURA but side effects can occur. If you experience swelling of the face, tongue or windpipe, see your doctor immediately. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. • Taking other medicines may sometimes cause problems. Check with your doctor or pharmacist before taking this or any other medicines. • If you are, or are trying to become pregnant, do not take DOXADURA and tell your doctor or pharmacist. WHAT IS IN THIS LEAFLET: 1. WHAT DOXADURA IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DOXADURA 3. HOW TO TAKE DOXADURA 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE DOXADURA 6. CONTENTS OF THE PACK AND OTHER INFORMATION The name of your medicine is DOXADURA 1 mg Tablets, DOXADURA 2 mg Tablets, DOXADURA 4 mg Tablets (referred to as DOXADURA throughout this leaflet). 1. WHAT DOXADURA IS AND WHAT IT IS USED FOR Doxazosin is one of a group of medicines called alpha- blockers. DOXADURA tablets are used to treat high blood pressure (hypertension) or the symptoms caused by enlargement of the prostate gland in men. In patients taking DOXADURA to treat high blood pressure (hypertension) DOXADURA works by relaxing blood vessels so that blood passes through them m Đọc toàn bộ tài liệu
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Doxazosin 2 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2.425 mg doxazosin mesilate equivalent to 2 mg of doxazosin. For the full list of excipients, see 6.1. 3. PHARMACEUTICAL FORM Tablet 2 mg: white oblong scored tablet, “D2” engraved on one side The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Essential hypertension. Symptomatic treatment of benign prostatic hyperplasia (BPH). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The duration of therapy will be decided by the physician. HYPERTENSION: The usual dosage limits of doxazosin lie between 1 and 8 mg per day. The maximum recommended dosage is 16 mg per day. The initial dosage is 1 mg, to be taken before retiring to bed. This dose is maintained for 1 or 2 weeks. The dose can then be increased to 2 mg once a day for another 1 or 2 weeks. If necessary the daily dose can then be gradually increased, observing equal intervals, to 4, 8 and 16 mg once a day, depending on the patient's response. BENIGN PROSTATE HYPERPLASIA: The initial dose of doxazosin is 1 mg (1 mg tablet) on the 1st to 8th day once daily and 2 mg (2 mg tablet) on the 9th to 14th day. Subsequently, dose should be titrated individually to 4 mg and to the maximum recommended dosage of 8 mg, depending on the urodynamic parameters and the BPH symptomatology of the patient. The recommended titration interval is 1 to 2 weeks. The usual recommended dose is 2-4 mg daily. Doxazosin is administered once a day. If the doxazosin treatment has been stopped for a number of days, the regimen should be determined again. USE IN ELDERLY PATIENTS AND USE IN RENALLY IMPAIRED PATIENTS: Because the pharmacokinetics of doxazosin remain unchanged in patients with renal insufficiency, and no evidence exists that doxazosin will exacerbate an existing renal insufficiency, the application of the usual dosages is ge Đọc toàn bộ tài liệu